Form 4 for IRD Opus Genetics, Inc.
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0001140361-22-013060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-05 | 2022-04-01 | IRD | Rodgers Richard J | Dir | A - Grant | — | +4,629 | 40.6K | +13% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | A | A | 4,629 | — | 40,623 | D | — | — | (F1) The Reporting Person was granted shares of common stock in lieu of cash for board services for the first quarter of 2022. The number of shares of common stock was determined by dividing (A) the aggregate amount of the retainer paid for board services for such fiscal quarter, by (B) the fair market value of the common stock on the last day of the fiscal quarter (rounded down to the nearest whole share). The fair market value was $3.24 per share, the closing price of the common stock on March 31, 2022. |